MEDAICA is a digital health company extending the reach and capability of remote care
We believe everyone should have simple and affordable access to healthcare.
See how we're making that happen.
Medaica’s platform and products are designed for interoperability to help future-proof our partners' operations.
FDA cleared M1 Telehealth Stethoscope designed for consumer scale and FREE for strategic partners supporting rural, or underserved patients and chronic heart and/or lung conditions.
Ease of use for patients, minimal workflow changes for healthcare professionals.
Plug & play, interoperable with any telemedicine platform.
There is a huge gap between willingness to use Telehealth and actual use in most medical specialties due to lack of easy to use, affordable and compatible platforms and relevant devices.
Sci-Fi's vision of the future included systems that could diagnose patients instantly. Reality is getting there but the devil is in the details.
Several digital devices and platforms today can diagnose a few conditions, but most are proprietary, expensive, difficult to use and rarely regulated for home use by consumers.
In our opinion (and the opinion of thought-leaders at the American Telehealth Association, American Medical Association, Centers for Disease Control and Prevention and Healthcare Information and Management Systems Society) we need platforms that support:
Interoperability of software and hardware to enable healthcare providers and patients to use any solutions that work with their existing systems.
Patient-centric design to deliver ease of use at an affordable price with regulatory clearance for “Over the Counter” home use and
An open ecosystem to support ever-changing and emerging 3rd Party AI, tools and devices.
Households USA, EU & UK
358M Households in the USA and Western Europe.
USA 133 M
World Bank 2020
~20% of Medicare, Medicaid, Outpatient, Office and Home Health spend could be virtualized.
Growth of "Digital First"
Consumer Digital Health
82% of consumers view digital options as the best way to monitor health
94% of healthcare professionals believe interoperability is critical.
Deloitte Insights 2020
CDC Fact Sheet 2019
Physician Office Visits in USA in 2019
503M Primary Care consultations in USA in 2019.
209,000 Primary Care Physicians in USA
Adults visited a Dr. last year
CDC Fact Sheet 2019
Patients in Licensed Nursing Homes in USA in 2019
CDC Fact Sheet 2019
20% people in the USA have been diagnosed with heart disease 27M, Asthma 25M, COPD 23M.
CDC Fact Sheet 2019
Telehealth diagnostic platform with FREE FDA-cleared stethoscope for remote auscultation.
- Improve the efficiency of supporting remote patients with more exam data and better outcomes.
Medaica Telehealth+ is an affordable and effective way for providers to extend their remote health capabilities.
More than basic telehealth video conferencing, Medaica Telehealth+ is a connected care platform that combines audio/video features with diagnostic tools and an FDA-cleared, Over The Counter (OTC) stethoscope, specifically designed for plug-and-play remote auscultation, so healthcare professionals can listen to a remote patient as easily and clearly as if they were in the clinic.
MEDAICA TELEHEALTH+ FEATURES
Cloud-based telehealth platform
Works with Chrome or any browser supporting Web RTC.
Supported platforms: iOS 15 and up, iPadOS 15 and up, Android 12 and up, Windows 10 and up, MacOS 10 and up.
Live, Store and Forward, Scheduled and In-Person.
3rd Party AI diagnostic support.
Secure. encrypted end-to-end, HIPAA compliant.
M1 Telehealth Stethoscope.
FDA cleared 510(k), Class II, OTC, intended to be used by professional users in a clinical environment or by lay users 18+ (and approved for over 65 yrs old) in a nonclinical environment.
Specifically designed for remote auscultation, patented two microphone design for intuitive multi-modal patient/ provider communications and auscultation recording.
Frequency response 20 - 3,500 Hz.
USB-C with included USB-2 and Lightning adapters.
Live-stream and near real-time lossless upload.
FREE for strategic partners supporting rural, or underserved patients and chronic heart and/or lung conditions.
Save and share recordings allowing for benchmarking, longitudinal and cohort comparisons.
Noise reduction: ambient, room and frictional.
Dimensions 134.5 x 17.5 x 33.4 mm.
Healthcare Provider interface includes stethoscope volume, bell, diaphragm and extended filters, auscultation position customization, auscultation notes, patient messaging, waiting room, patient present alert, and export to EMR.
Remotely detect patient’s stethoscope status and record start/stop.
Remote exams (e.g. rural, schools, corporate), Chronic patient follow up, reduce readmissions, clinical education, in field EMS triage and clinical support.
HOW TO BUY
Medaica Telehealth+ is sold as either an annual license on a per visit/per stethoscope or per host model. The FDA cleared Medaica M1 Stethoscope is available FREE for strategic partners supporting rural, or underserved patients and chronic heart and/or lung conditions. Contact us.
End-to-End Virtual Care Use Cases
MEDAICA is working on a cause-driven campaign under the banner of EveryBeatEveryBreath.org, to provide telehealth solutions with free stethoscopes to remote, underserved communities and disadvantaged groups.
In the USA, nearly 53 million people (16% of population) live more than 30 miles from a hospital or urgent care. Globally, an estimated one billion people have no access to essential health-care services.
The campaign aims to raise awareness of this issue and underpins MEDAICA’s Mission "to extend the reach and capability of remote care” and Vision that “Everyone in the world has affordable access to healthcare.”
Contact us to learn more.
We are passionate about making remote care available to everyone, simply and affordably.
Medaica was founded by serial entrepreneurs with multiple successful exits, a combined 50+ years in health technology and medical businesses and over 100 years in software platforms.
Our team has the unique experience of designing, developing and shipping innovative, robust, secure and scalable software and consumer electronics, used by hundreds of millions of people worldwide.
We have helped catalyze change in other industries and we are working to do the same in digital health. Starting by making it more open and interoperable, enabling AI and other products and services to leverage data.
Ultimately, we believe open platforms will accelerate innovation and lead to more efficient and more affordable healthcare and better outcomes. For everyone.
Partnerships are critical to achieving what we're building.
Please contact us to learn more.
Stephen is serial entrepreneur with global experience building technology platform businesses. Prior to Medaica, he was COO of M3dicine, a MedTech device company and CEO of LocaModa Inc., a Digital Out of Home platform company (acquired by Monster Media). Stephen was also a Founder and COO of Symbian, the mobile OS platform company jointly owned by Nokia, Sony Ericsson, Motorola, Matsushita, Motorola and Psion (acquired by Nokia), Joint CEO of Psion Software PLC., a mobile computing company and Founder/CEO of Eden Group (acquired by Geoworks). He is a recipient of the British Design Award for the Stepp Digital Guitar. Architecture - Cardiff University.
President / CFO
Before MEDAICA, Pablo was CFO at M3dicine a MedTech company and CEO of AmeriMed, the largest chain of American hospitals in Mexico where he led the company turnaround. With 15 years of experience in M&A at European and American banks, he led multiple cross-border deals in Healthcare, Biotech, Health Insurance and Pharma. Besides Medaica, he co-founded 2 companies in the technology space, both currently in growth stage and advised many others. Angel investor. Pablo holds a Wharton MBA, MA in International Studies from Univ. of Penn/Lauder Institute and a post-grad degree in Mgmt. from Harvard University.
Consumer and technology product expert who has deployed >100million connected devices in over 40 countries globally (Satnav, Health-tech and Sports wearables). Former CEO of AYR and over 12 years as COO of TomTom N.V., digital map and content provider.
Over 35 years’ experience in early-stage companies through to IPO and onto consumer brands with global recognition.
Builder of high-performance companies, products and teams. Deep expertise in supply chain and operations management.
MBA - Univ. Hertfordshire.
Mark has over thirty years of technology management including senior management/CTO roles at several start ups including Psion PLC where he developed one of the first ARM based application specific processor chips. Former CTO of TomTom N.V. where he led the transition from a small software company into a large international consumer electronics brand. He built the engineering team that developed the company’s ground-breaking range of navigation and Health-tech devices with over a 100m units sold. BSc Engineering - University of Reading.
DR. JENNIFER PEÑA
Chief Medical Officer
Dr. Peña served as White House physician under both the Obama and Trump administrations, and Physician to the Vice President of the United States. A former US Army combat veteran, Dr. Peña is a digital and telehealth expert, clinical leader and board-certified internal medicine physician. Dr. Peña directs the Vidalús free clinic of the Boys and Girls Club of Puerto Rico and is a fellow of the American College of Physicians (ACP) and member of the American Telemedicine Association's Advisory Group to Eliminate Healthcare Disparities and Inequalities. BS-Yale University. MD-University of Pittsburgh School of Medicine. Residency-Walter Reed Army Medical Center.
Head of Software
Before MEDAICA, Nick was founder and Head of Software at Double Down Interactive (acquired by IGT) an entertainment software company.
Nick led platform development from concept, and launch, to scale to 4.7 million monthly active users and exit ($500M). Prior to Double Down Interactive, Nick had 20+ years developing software platforms for startups and Fortune 100 companies such as IBM, AT&T, and Intel. Angel investor.
BA, Philosophy and Literature – Univ of Toronto
Head of Product
20+ years experience developing high-end technology applications and solutions. Before MEDAICA Dan was CPO of iPro and helped develop the product. Prior to iPro, Dan was founder and Head of Product at Double Down Interactive (acquired by IGT) an entertainment software company that he helped to grow to support over 1 million daily players, 100+ employees, and one of the top grossing iPad and Facebook applications. Dan is also Head of Technology for Drop in the Bucket, a non-profit building wells and sanitations systems at schools in Africa. Board member at IndieFlix Group Inc. Angel Investor. Berklee College of Music
Clinical Advisory Board
Medaica’s Clinical Advisory Board helps the company continuously improve our products
by identifying areas where we add the most value to providers and patients.
The board comprises world-renowned clinicians spanning the The White House Medical Unit,
Emory, USCSF and the International Institute of Cardiology.
Dr. Byron Williams Jr. is Emeritus Chief of Medicine at Emory University Hospital. He received his medical degree from University of Florida College of Medicine.
Dr. Vicente Bertomeu is the Dean of Cardiology at UMH in Elche (Spain) and the Head of the Cardiology Research Center at San Juan University Hospital, Alicante, Spain.
Dr. Jennifer Peña served as White House physician under both the Obama and Trump administrations, and Physician to the Vice President of the United States. A digital and telehealth expert, clinical leader and board-certified internal medicine physician.
Julie Gregg is a Certified Registered Nurse Anesthetist at the Veterans Administration in the USA and is a Principal Investigator for research investigating systolic and diastolic duration.
Laurie McGraw is a recognized healthcare leader, previously American Medical Association (AMA) SVP; President AMA Innovations; President at Allscripts.
Dr. Danny Weiss is a cardiac electrophysiologist and an author of “An in vitro acoustic analysis and comparison of popular stethoscopes” a leading peer reviewed white paper for digital stethoscope performance testing.
Dr. Adithya Cattamanchi is Professor of Medicine and Epidemiology at UCSF and UC Irvine. He also conducts research with the Gates Foundation focused on diagnostics for tuberculosis.
Dr. Cordero is a sports cardiologist and a Professor of the International Institute of Cardiology. He is the author of numerous publications as well as the Head of the Cardiac Rehabilitation of the Spanish Cardiology Society.
Dr. Tony Das is a nationally recognized board-certified interventional cardiology specialist who has been leading national programs to incorporate remote monitoring to improve care for cardiovascular patients by reducing hospitalizations and office visits